Asha Therapeutics Receives ALS Grant & Appoints Disarm Founders
13 Nov 2024 //
BUSINESSWIRE
Asha Announces the Nomination of ASHA-624 as a Modifying Therapeutic for ALS
01 Apr 2024 //
BUSINESSWIRE
13 Nov 2024 //
BUSINESSWIRE
01 Apr 2024 //
BUSINESSWIRE